TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SCLX

Scilex Holding Company

Healthcare · Drug Manufacturers - General

5.40$ +3.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Scilex Holding Company (SCLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 30 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SCLX
Line item 2019 2020 2021 2022 2023 2024 2025
21 24 31 38 47 57 30
5.8 2.1 3.6 11 16 17 15
15 21 28 27 31 40 15
86 10.0 9.2 9.1 13 9.6 21
65 43 51 65 120 119 267
154 57 64 78 136 123 287
-139 -35 -36 -51 -105 -83 -272
17 13 12 9.6 1.1 2.0 11
-179 -48 -88 -23 -114 -73 -374
0.0 -0.1 0.0 0.0 0.0 0.0 0.0
-179 -48 -88 -23 -114 -73 -359
-158 -31 -73 -9.3 -109 -67 -358

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?